Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Transfusion. 2017 Jul 13;57(10):2440–2448. doi: 10.1111/trf.14226

TABLE 5.

Low hemoglobin deferral rates during pre-STRIDE, STRIDE, and post-STRIDE, N = 692 donors

Group assignment* Pre-STRIDE, % STRIDE, % p value Post-STRIDE, % p value
Iron status information only 5.0 5.2 0.58 3.8 0.63
No information or treatment 5.1 10.7 0.0004 4.9 0.80
Iron 38 mg × 60 days 5.2 3.1 0.09 9.4 0.03
Iron 19 mg × 60days 5.1 3.2 0.06 7.5 0.07
Placebo × 60 days 3.7 8.3 0.0006 4.8 0.42
Test for differences across group assignments§ p = 0.73 p = 0.0002 p = 0.59
*

All donors are included. Group assignments are specified in Fig. 1.

The deferral rate was calculated as: # of hemoglobin deferrals % (# of deferrals + successful and quantity-not-sufficient donations).

Test for change from pre-STRIDE from repeated measures model (see Materials and Methods).

§

Test for common differences among group assignments from repeated measures model (see Materials and Methods).